Chronic Wound Care Market (By Product: Advanced Dressing, Surgical & Traditional Wound Care, Wound Therapy Devices; By Application: Diabetic Foot Ulcers; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The global chronic wound care market was valued at USD 12.86 billion in 2022 and it is predicted to surpass around USD 19.16 billion by 2032 with a CAGR of 4.07% from 2023 to 2032.

Chronic Wound Care Market Size 2022 to 2032

Report Highlights

  • Advanced wound dressing dominated the product segment of the market with a market share of 35.1% in 2022 and is expected to witness the fastest growth over the forecast period.
  • In 2022, based on end-use, the hospital segment accounted for the maximum revenue share with around 46.03%.
  • Based on application, the diabetic foot ulcers segment dominated the market in 2022 with a market share of 35.03%. 
  • North America was identified as the most revenue-generating region in 2022 with over 45.11%.

Diabetes may increase the overall frequency and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and chronic wounds, including surgical & traumatic wounds. For instance, according to a research article published in March 2021 by ScienceDirect, the prevalence of diabetes is expected to increase to 120 million people in 2032, thereby propelling market growth.

The outbreak of COVID-19 has created large-scale opportunities for local manufacturers. Due to the restrictions on movement at international borders, the supply chain of major players has been disrupted. This has created an opportunity for local players to enter the market and meet the unmet demands of the end-users. The rising number of cases has led to a shortage of medical supplies; thus, local players are manufacturing products on a larger scale to meet the growing need. Moreover, to enhance their foothold in the market, key companies are adopting various plans and policies to gain a higher market share.

Technological advancements are projected to have a significant impact on the advanced wound care industry in the coming years. The quality of life of patients suffering from chronic wounds improves as technology advances and becomes more affordable. Traditional wound care and closure products are gradually being replaced by advanced wound care & closure products due to their efficacy and effectiveness in wound management by allowing quicker healing.

Report Coverage Details
Market Size in 2022 USD 12.86 billion
Revenue Forecast by 2032 USD 19.16 billion
Growth rate from 2023 to 2032 CAGR of 4.07%
Base Year 2022
Forecast Period 2023 to 2032
Segmentation Product, application, end-use, region
Companies Covered Johnson & Johnson; Baxter International; Coloplast Corp.; 3M; Medline Industries, Inc.; ConvaTec Group PLC; Derma Sciences (Integra LifeSciences); Mölnlycke Health Care AB; Paul Hartmann AG; Smith & Nephew PL

 

Product Insights

Advanced wound dressing dominated the product segment of the market with a market share of 35.1% in 2022 and is expected to witness the fastest growth over the forecast period due to an increase in technological advancement, rising cases of chronic diseases, and an increase in the number of sports-related injuries.

Based on products, the wound care market is segmented into traditional wound dressings, advanced wound dressings, surgical wound dressings, and wound therapy devices. The market is expected to witness significant growth owing to the increasing prevalence of chronic diseases such as diabetic foot ulcers and venous leg ulcers. Moreover, the rising geriatric population across the globe is also expected to boost the market growth. Increasing awareness of surgical site infection and rising disposable income are other major factors that are expected to foster market growth.

Foam dressing helps in absorbing the moisture that aids in maintaining the integrity of the tissue. The increasing cases of trauma and pressure ulcer patients across the globe are expected to propel the segment growth. For instance, as per the Agency for Healthcare Research and Quality, every year, more than 2.5 million people in the U.S. develop pressure ulcers. Foams are mainly used to protect skin breakdown due to friction, aiding chronic wound management and propelling the segment growth over the forecast period.

End-use Insights

In 2022, based on end-use, the hospital segment accounted for the maximum revenue share with around 46.03% owing to the increasing number of surgeries, globally. However, the home healthcare segment is anticipated to witness the fastest growth rate of 4.90% during the forecast period due to the increase in demand for reduced hospital stays.

Increasing surgical procedures, rising incidence of diabetic foot ulcers, and an increasing number of hospitals are among the major factors driving the segment growth. As per the latest survey by the American Hospital Association, the total number of hospitals in the U.S. is estimated to be 6,093 in 2022. Similarly, as per reports, there has been a constant increase in the number of hospitals in the U.K., as the number of hospitals has increased to 1,978 in 2019. Thus, such factors may increase the number of surgeries, and therefore may surge the segment growth over the forecast period.

Wound care in homecare settings was majorly initiated with the introduction of single-use NPWT systems. These devices are lightweight, portable, canister-free, and easy to use. In addition, the cost-effectiveness of such therapy for treating wounds also encourages patients to adopt homecare settings over hospital stays.

Application Insights

Based on application, the diabetic foot ulcers segment dominated the market in 2022 with a market share of 35.03%. This can be attributed to the increase in the number of diabetic patients globally. However, the pressure ulcers segment is anticipated to witness the fastest growth over the forecast period owing to the increasing prevalence of obesity and related wounds.

Pressure ulcers are injuries to the skin and underlying tissues, which are a result of prolonged pressure on the skin. This can be caused due to prolonged hospitalization and being unable to move, which especially happens in old age and in case of sudden weight loss. For instance, according to Agency for Healthcare Research and Quality, more than 2.5 million people in the U.S. develop pressure ulcers every year. Similarly, according to NCBI, the incidence of pressure ulcers in a clinical setting may range from 4.0% to 38.0%. In addition, according to a similar source, the mortality rate due to pressure ulcers and associated disorders is estimated to be approximately 68.0% in adults. As the geriatric population is more vulnerable to pressure ulcers, an increase in the geriatric population may lead to a rise in the number of pressure ulcer patients, which is expected to propel segment growth over the forecast period.

Regional Insights

North America was identified as the most revenue-generating region in 2022 with over 45.11% share of the chronic wound care market. Increasing sports injuries, road accidents, and the presence of several key players in the region are anticipated to drive the market in North America. For instance, as per the National Institute of Diabetes and Digestive Kidney Diseases, an estimated 34.2 million people have diabetes, which comprises 10.5% of the U.S. Additionally, 88 million adults people aged 18 years & older have prediabetes, which may further increase the chronic diseases in this region. Similarly, the availability of skilled professionals, improvement in healthcare infrastructure, and presence of major market players are also expected to drive the market over the forecast period.

Asia Pacific wound care market is anticipated to witness the fastest growth over the forecast period. The presence of developing countries such as China, India, and Japan is anticipated to boost market growth in the Asia Pacific region. In addition, with a rapidly aging population in this region, along with an increasing number of obese and diabetic patients, the use of chronic wounds in this region is anticipated to increase. Moreover, medical tourism in this region has also been attributed to the increase in demand for chronic wound care products.

The rising geriatric population is one of the major driving factors for the market growth in Japan. According to Europa, more than one in four people are above 65 years of age. As the geriatric population is at a higher risk of various diseases and disabilities, an increase in the elderly population may propel the demand for wound care products.

Key Players

  • JOHNSON & JOHNSON
  • BAXTER INTERNATIONAL
  • Coloplast Corp.
  • 3M
  • Medline Industries, Inc.
  • ConvaTec Group PLC
  • Derma Sciences (Integra LifeSciences)
  • Mölnlycke Health Care AB
  • Paul Hartmann AG
  • Smith & Nephew PLC

Market Segmentation

  • By Product Outlook
    • Advanced Wound Dressing
      • Foam Dressing
      • Hydrocolloid Dressing
      • Film Dressing
      • Alginate Dressing
      • Hydrogel Dressing
      • Collagen Dressing
      • Other Dressing
    • Surgical Wound Care
      • Suture & Staples
      • Tissue Adhesive & Sealants
      • Anti-infective Dressing
    • Traditional Wound Care
      • Medical Tapes
      • Cleansing Agents
      • Others
    • Wound Therapy Devices
      • Negative Pressure Wound Therapy
      • Oxygen and Hyperbaric Oxygen Equipment
      • Electric Stimulation Devices
      • Pressure Relief Devices
      • Others
  • By Application Outlook
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Venous Leg Ulcers
    • Others
  • By End-use Outlook
    • Hospitals
    • Specialty Clinics
    • Home Healthcare
    • Others
  • By Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Australia
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • MEA
      • South Africa
      • Saudi Arabia
      • UAE

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Chronic Wound Care Market 

5.1. COVID-19 Landscape: Chronic Wound Care Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Chronic Wound Care Market, By Product

8.1. Chronic Wound Care Market, by Product, 2023-2032

8.1.1 Advanced Wound Dressing

8.1.1.1. Market Revenue and Forecast (2019-2032)

8.1.2. Surgical Wound Care

8.1.2.1. Market Revenue and Forecast (2019-2032)

8.1.3. Traditional Wound Care

8.1.3.1. Market Revenue and Forecast (2019-2032)

8.1.4. Wound Therapy Devices

8.1.4.1. Market Revenue and Forecast (2019-2032)

Chapter 9. Global Chronic Wound Care Market, By Application

9.1. Chronic Wound Care Market, by Application, 2023-2032

9.1.1. Diabetic Foot Ulcers

9.1.1.1. Market Revenue and Forecast (2019-2032)

9.1.2. Pressure Ulcers

9.1.2.1. Market Revenue and Forecast (2019-2032)

9.1.3. Venous Leg Ulcers

9.1.3.1. Market Revenue and Forecast (2019-2032)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2019-2032)

Chapter 10. Global Chronic Wound Care Market, By End-use 

10.1. Chronic Wound Care Market, by End-use, 2023-2032

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2019-2032)

10.1.2. Specialty Clinics

10.1.2.1. Market Revenue and Forecast (2019-2032)

10.1.3. Home Healthcare

10.1.3.1. Market Revenue and Forecast (2019-2032)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2019-2032)

Chapter 11. Global Chronic Wound Care Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2019-2032)

11.1.2. Market Revenue and Forecast, by Application (2019-2032)

11.1.3. Market Revenue and Forecast, by End-use (2019-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2019-2032)

11.1.4.2. Market Revenue and Forecast, by Application (2019-2032)

11.1.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2019-2032)

11.1.5.2. Market Revenue and Forecast, by Application (2019-2032)

11.1.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2019-2032)

11.2.2. Market Revenue and Forecast, by Application (2019-2032)

11.2.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2019-2032)

11.2.4.2. Market Revenue and Forecast, by Application (2019-2032)

11.2.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2019-2032)

11.2.5.2. Market Revenue and Forecast, by Application (2019-2032)

11.2.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2019-2032)

11.2.6.2. Market Revenue and Forecast, by Application (2019-2032)

11.2.6.3. Market Revenue and Forecast, by End-use (2019-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2019-2032)

11.2.7.2. Market Revenue and Forecast, by Application (2019-2032)

11.2.7.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2019-2032)

11.3.2. Market Revenue and Forecast, by Application (2019-2032)

11.3.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2019-2032)

11.3.4.2. Market Revenue and Forecast, by Application (2019-2032)

11.3.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2019-2032)

11.3.5.2. Market Revenue and Forecast, by Application (2019-2032)

11.3.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2019-2032)

11.3.6.2. Market Revenue and Forecast, by Application (2019-2032)

11.3.6.3. Market Revenue and Forecast, by End-use (2019-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2019-2032)

11.3.7.2. Market Revenue and Forecast, by Application (2019-2032)

11.3.7.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2019-2032)

11.4.2. Market Revenue and Forecast, by Application (2019-2032)

11.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2019-2032)

11.4.4.2. Market Revenue and Forecast, by Application (2019-2032)

11.4.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2019-2032)

11.4.5.2. Market Revenue and Forecast, by Application (2019-2032)

11.4.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2019-2032)

11.4.6.2. Market Revenue and Forecast, by Application (2019-2032)

11.4.6.3. Market Revenue and Forecast, by End-use (2019-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2019-2032)

11.4.7.2. Market Revenue and Forecast, by Application (2019-2032)

11.4.7.3. Market Revenue and Forecast, by End-use (2019-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2019-2032)

11.5.2. Market Revenue and Forecast, by Application (2019-2032)

11.5.3. Market Revenue and Forecast, by End-use (2019-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2019-2032)

11.5.4.2. Market Revenue and Forecast, by Application (2019-2032)

11.5.4.3. Market Revenue and Forecast, by End-use (2019-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2019-2032)

11.5.5.2. Market Revenue and Forecast, by Application (2019-2032)

11.5.5.3. Market Revenue and Forecast, by End-use (2019-2032)

Chapter 12. Company Profiles

12.1. JOHNSON & JOHNSON

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. BAXTER INTERNATIONAL

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Coloplast Corp.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. 3M

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Medline Industries, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. ConvaTec Group PLC

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Derma Sciences (Integra LifeSciences)

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Mölnlycke Health Care AB

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Paul Hartmann AG

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Paul Hartmann AG

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers